Photo for representation only.
New Delhi, May 17
The Union Chemical Ministry on Monday said country’s Remdesivir production capacity has increased from 38 lakh vials per month to nearly 119 lakh vials per month.
“With the efforts of the Centre and the manufacturing companies, the production capacity of the licensed manufacturers has increased unprecedentedly,” the Department of Pharmaceuticals of the Ministry said.
Remdesivir is a patented drug, manufactured in India under voluntary licences granted by Gilead Life Sciences USA, the patent holder, to seven Indian pharmaceutical companies (Cipla, Dr Reddy’s Lab, Hetero, Jubilant Pharma, Mylan, Syngene and Zydus Cadila).
To augment the domestic production capacity, all seven domestic licensed manufacturers of Remdesivir were asked to ramp up production quickly. — TNS
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
‘Congress mantra is loot in life, loot after life’: PM Modi on Sam Pitroda’s 'inheritance tax' remarks
Grand Old Party accuses BJP of distorting Pitroda’s remarks ...
Congress distances itself from Sam Pitroda’s ‘inheritance tax' remarks; Pitroda says ‘statement twisted to divert attention’
Pitroda, the president of the Indian Overseas Congress, had ...
Congress suspends Punjab’s Phillaur MLA Vikramjit Chaudhary over statements against ex-CM Charanjit Channi
The suspension letter has been issued by Congress’s Punjab a...
Amritpal Singh to contest Lok Sabha election from Punjab’s Khadoor Sahib, claims lawyer
His father refuses to comment
VVPAT: ‘We can’t control elections’, Supreme Court tells petitioners
The Bench, which has already reserved its verdict, told the ...
